Diovan (Chronic Heart Failure)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Related Reports 8
3 Disease Overview 10
3.1 Etiology and Pathophysiology 10
3.1.1 Etiology 10
3.1.2 Pathophysiology 12
3.2 Prognosis 16
3.3 Quality of Life 16
3.4 Symptoms 17
4 Disease Management 19
4.1 Treatment Overview 20
4.1.1 Pharmacological Treatments 22
4.1.2 Mechanical Devices 28
5 Competitive Assessment 29
5.1 Overview 29
5.2 Strategic Competitor Assessment 29
6 Diovan (valsartan) 32
6.1 Overview 32
6.2 Efficacy 34
6.3 Safety 34
6.4 SWOT Analysis 35
6.5 Forecast 36
7 Appendix 37
7.1 Bibliography 37
7.2 Abbreviations 39
7.3 Methodology 41
7.4 Forecasting Methodology 41
7.4.1 NYHA Class Segmentation of Total Prevalent CHF Population 41
7.4.2 Diagnosed CHF Population 42
7.4.3 Drug-Treated CHF Population 43
7.4.4 Patient Population Breakdown: HF-REF versus HF-PEF 43
7.4.5 Treatment of HF-REF versus HF-PEF 43
7.4.6 General Pricing Assumptions 44
7.4.7 Drugs Assumptions 45
7.4.8 Generic Erosion 45
7.5 Physicians and Specialists Included in this Study 46
7.6 Survey of Prescribing Physicians 47
7.7 About the Authors 48
7.7.1 Author 48
7.7.2 Global Head of Healthcare 48
7.8 About GlobalData 49
7.9 Disclaimer 49